SynthesisUpdates in surgery2013
The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review.
Synthesis in Updates in surgery, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 45 citations in OpenAlex.
- The robotic single-port platform for gynecologic surgery: a systematic review of the literature and meta-analysis.Updates in surgery · 2021Pooled it
- Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review.Journal of ovarian research · 2019Pooled it
- Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives.International journal of molecular sciences · 2017Pooled it
- Editorial: Minimally invasive surgery in gynecology oncology: current trends and controversies.Frontiers in medicine · 2023Article
- CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo.Journal of ovarian research · 2019Article
- Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies using new hybrid COUpdates in surgery · 2019Article
- A novel HIPEC technique using hybrid COUpdates in surgery · 2018Article
- A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience.Journal of ovarian research · 2018Article
- Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice?Updates in surgery · 2017Review
- New procedures for the identification of sentinel lymph node: shaping the horizon of future management in early stage uterine cervical cancer.Updates in surgery · 2017Review
- Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up.Updates in surgery · 2017Article
- Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives.Updates in surgery · 2017Review
- Psychological impact of fertility preservation techniques in women with gynaecological cancer.Ecancermedicalscience · 2017Article
- Comment on: "The consequences of gynaecological cancer in patients and their partners from the sexual and psychological perspective".Przeglad menopauzalny = Menopause review · 2016Article
- Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer.International journal of cancer · 2015Article
- The Importance of Fertility Preservation Counseling in Patients with Gynecologic Cancer.Journal of reproduction & infertilityArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It has already been proven that ovarian cancer is the sixth most common cancer among women, and it is considered the leading cause of death by gynecologic cancer in developed countries. This article is a literature review based on the use of cytoreductive surgery matched with adjuvant chemotherapy in advanced-stage ovarian cancer. According to the statistics, the difficulty of obtaining an early diagnosis results in a delay in the disease treatment and as a consequence, in many cases, ovarian cancer is still diagnosed in the advanced stage of the disease. Primary surgery is performed, in addition to diagnosis and staging, to achieve optimal cytoreduction. The purpose of this article is to review the different surgical approaches in the management of epithelial ovarian cancer, specifically the high-stage disease, with a special concentration on the most recent therapeutic additions to our current knowledge, such as hyperthermic intraperitoneal chemotherapy and new therapeutic drugs. Surgical treatment still plays a pivotal role in the management of advanced-stage ovarian cancer. Complete cytoreduction continues to be, when feasible, the objective to be attempted in the surgical treatment of advanced ovarian cancer. Obviously, the success of the operation depends on numerous factors, including patient selection, the locations of tumors, and surgeon expertise. To offer patients the best possible outcome with the least accompanying morbidity, strong consideration should be given to the referral of such patients to expert care centers for primary surgery, because it may be the best means currently available for improving overall survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.